Hamon Center Therapeutic Oncology - Minna Lab

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 85%
3. Neoplasms 50%
4. Cell Line 41%
5. Genes 33%
6. Small Cell Lung Carcinoma 29%
7. Lung 26%
8. Adenocarcinoma of Lung 23%
9. Epithelial Cells 21%
10. Gene Expression 19%
11. Mutation 18%
12. Oncogenes 18%
13. Tumor Suppressor Genes 15%
14. ErbB Receptors 15%
15. Methylation 14%
16. Breast Neoplasms 14%
17. Growth 14%
18. Epithelial-Mesenchymal Transition 13%
19. Carcinogenesis 12%
20. Genome 12%
21. Proteins 12%
22. Apoptosis 11%
23. Phenotype 10%
24. DNA Mismatch Repair 10%
25. Therapeutics 10%
26. Biomarkers 10%
27. Heterografts 10%
28. Survival 9%
29. Transcriptome 9%
30. Datasets 9%
31. DNA Methylation 9%
32. DNA 8%
33. Microsatellite Instability 8%
34. Squamous Cell Carcinoma 8%
35. Messenger RNA 8%
36. Adenocarcinoma 8%
37. Epigenomics 7%
38. Poly (ADP-Ribose) Polymerase-1 7%
39. Tumor Cell Line 7%
40. Transcription Factors 7%
41. Alleles 7%
42. Pharmaceutical Preparations 6%
43. Small Interfering RNA 6%
44. alpha-2'-deoxythioguanosine 6%
45. Erlotinib Hydrochloride 6%
46. Pancreatic Neoplasms 6%
47. Chromosomes 6%
48. Carcinoma 6%
49. Microsatellite Repeats 6%
50. Cell Cycle 6%
51. Radiation 6%
52. Loss of Heterozygosity 6%
53. Notch1 Receptor 5%
54. Cell Survival 5%
55. Transgenic Mice 5%
56. In Vitro Techniques 5%
57. Proteomics 5%
58. Cytoplasmic and Nuclear Receptors 5%
59. Microarray Analysis 5%
60. Genomics 5%
61. Phosphotransferases 5%
62. Neoplasm Metastasis 5%
63. Drug Therapy 5%
64. Neoplasm Genes 5%
65. Single Nucleotide Polymorphism 5%
66. pyrimidine 5%
67. Neuroendocrine Tumors 5%
68. Protein-Tyrosine Kinases 5%
69. Gefitinib 5%
70. Oligonucleotide Array Sequence Analysis 5%
71. Cell Movement 5%
72. Cell Proliferation 5%
73. Human Chromosomes 5%
74. Ionizing Radiation 5%
75. Up-Regulation 5%
76. Neuroendocrine Carcinoma 5%